THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
I’m Dreaming of a Glow-in-the-Dark Christmas Tree
Imagine a holiday season where your Christmas tree glows naturally—no tangled strings of lights or electricity required. Advances in biotechnology are turning this dream into a reality.
Therapeutic Antibodies Explained
Antibody therapeutics have revolutionized treatment for many diseases, from cancer to autoimmune disorders. Read on to learn how they work.
Vaccines: Elegant, Powerful, and Lifesaving
Vaccines are the ultimate cheat code for your immune system—arming it to fight deadly germs before you’re ever in danger.
World AIDS Day: Why It Still Matters
December 1 will mark World AIDS Day, a time to spotlight the ongoing fight against HIV/AIDS. HIV doesn’t directly kill people—it’s the opportunistic infections that come with a weakened immune system that are deadly.
Get Ahead With Life Science Executive Certifications
Working professionals in exciting, dynamic industries like biotech, pharma, and med device have much to gain by keeping up with the latest technologies, best practices, and scientific techniques.
Your Competitive Edge
Continuing professional education (CPE) courses offer an edge, enabling life science financial professionals to keep pace with innovations, advance their careers, and sharpen in-demand skills.
Cell Line Madness
The production of biologics depends on cell lines—living factories that originate from a primary culture and have the remarkable ability to grow and multiply.
Stump the Clumps: Treating Amyloidosis
Amyloid is a protein that builds up in the liver, spleen, and other tissues. When amyloid folds incorrectly, the protein sticks together and forms fibrous deposits in and around cells, causing amyloidosis. Fortunately, affected patients are benefitting from new, cutting-edge treatment options.
Silencing Disease: Unveiling the Potential of ASO’s
Antisense oligonucleotide (ASO) technology revolutionizes disease treatment by specifically targeting and modifying RNA. This therapeutic class is rapidly gaining traction due to its precision in targeting proteins that are inaccessible to traditional treatments.
Special Delivery: Gene Therapy Vectors
There are two broad approaches to gene therapy treatment, in vivo and ex vivo, and each relies on a different gene vector to get the job done. Let’s take a closer look.
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.